--- title: Insights --- # Insights [![ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt](https://www.crosstreecapital.com/hubfs/ROI%20Healthcare%20Deal%20Featured%20Image%20(1).png) Deal Insights #### ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt Learn More ](https://www.crosstreecapital.com/hubfs/ROI%20Deal%20Announcement.pdf?hsLang=en) [![Pharma Services: Drug Development BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-14T103931.881.png) BlueBook #### Pharma Services: Drug Development BlueBook March 2025 Highlights from this edition: Clinilabs was acquired by InTandem Capital Partners, Kardigan announced its acquisition of Prolaio, Mendel Health closed a $35MM Series B Financing, led by Industry Ventures, BECO Capital, Hi Ventures, Base10 Partners Capital Management, PayPal Ventures and Infinity Ventures Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-march-2025?hsLang=en) [![Pharma Services: Drug Supply Chain BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-16T103632.637.png) BlueBook #### Pharma Services: Drug Supply Chain BlueBook March 2025 Highlights from this edition: Gateway Medical Pharmacy was acquired by Medicure Pharma, RedSail Technologies announced its acquisition of Emporos Systems, Strong Room Technology closed a $17MM Series A Financing, led by Artesian Capital Management, Equity Venture Partners and InterValley Ventures Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-march-2025?hsLang=en) [![Pharma Services: Pharmaceutical Commerce BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-16T110543.792.png) BlueBook #### Pharma Services: Pharmaceutical Commerce BlueBook March 2025 Highlights from this edition: Mercalis was acquired by PharmaCord, TIS International announced its acquisition of Glidian, Silna Health closed a $22MM Series A Financing, led by Accel Partners and Bain Capital Ventures Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-march-2025?hsLang=en) [![Pharma Services: Pharma Technology BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-22T150033.284.png) BlueBook #### Pharma Services: Pharma Technology BlueBook March 2025 Highlights from this edition: Deep 6 AI was acquired by Tempus AI, PharmaCord announced its acquisition of Mercalis, Experiad closed a $27MM Series A Financing, led by First Trust Capital Partners Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-march-2025?hsLang=en) [![IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-17T150049.946.png) Deal Insights #### IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20IPeople%20+%20RLDatix.pdf?hsLang=en) / 6 Type Type Article Bluebook Case Study Deal Insight Market Map Video Whitepaper Industry Industry Precision Medicine Pharma Services Diagnostics and Tools Digital Health Clear All [![Pharma Services September 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/PS-July-BB-Website-Image-1.png) ###### Bluebook #### Pharma Services September 2023 Highlights from this edition: Vax Trials was acquired by The Emmes Company, LLC Grant Avenue Capital, LLC announced its acquisition... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-2023?hsLang=en) [![Diagnostics and Tools September 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/PS-July-BB-Website-Image-2.png) ###### Bluebook #### Diagnostics and Tools September 2023 Highlights from this edition: Gedi Cube was acquired by Renovaro Biosciences Inc. (NasdaqCM:RENB) Repligen Corporation (NasdaqGS:RGEN) announced its ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-2023?hsLang=en) [![Pharma Services October 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-51.png) ###### Bluebook #### Pharma Services October 2023 Highlights from this edition: Clinical Trial Data Services was acquired by Veramed Limited P95 announced its acquisition of Clinical Research... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-2023?hsLang=en) [![Diagnostics and Tools October 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-52.png) ###### Bluebook #### Diagnostics and Tools October 2023 Highlights from this edition: Olink Holding AB (NasdaqGM:OLK) was acquired by Thermo Fisher Scientific Inc. (NYSE:TMO) iCON Infrastructure LLP ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-2023?hsLang=en) [![Pharma Services November 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-53.png) ###### Bluebook #### Pharma Services November 2023 Highlights from this edition: PhysIQ was acquired by Prolaio Gauge Capital announced its acquisition of East Coast Institute for Research... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-2023?hsLang=en) [![Pharma Services January 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Pharma Services January 2019 Transactions in the Pharma Services – Development industry totaled ten mergers & acquisitions and one financing during the month of... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-january-2019?hsLang=en) [![Diagnostics & Tools January 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools January 2019 Transactions in the Diagnostics & Tools industry totaled fourteen mergers & acquisitions and eighteen financings during the month of January... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-january-2019?hsLang=en) [![Diagnostics & Tools February 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools February 2019 Transactions in the Diagnostics & Tools industry totaled eleven mergers & acquisitions and seventeen financings during the month of February... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-february-2019?hsLang=en) [![Pharma Services February 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Pharma Services February 2019 Transactions in the Pharma Services industry totaled eleven mergers & acquisitions and three financings during the month of February In... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-february-2019?hsLang=en) [![Diagnostics & Tools March 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools March 2019 Transactions in the Diagnostics & Tools industry totaled fifteen mergers & acquisitions and twenty-four financings during the month of March... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-march-2019?hsLang=en) [![Pharma Services March 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Pharma Services March 2019 Transactions in the Pharma Services – Development industry totaled six mergers & acquisitions and three financings during the month of... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-march-2019?hsLang=en) [![Diagnostics & Tools April 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools April 2019 Transactions in the Diagnostics & Tools industry totaled eleven mergers & acquisitions and twenty-five financings during the month of April... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-april-2019?hsLang=en) [![Pharma Services April 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Pharma Services April 2019 Transactions in the Pharma Services – Development industry totaled five mergers & acquisitions and two financings during the month of... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-april-2019?hsLang=en) [![Diagnostics & Tools May 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools May 2019 Transactions in the Diagnostics & Tools industry totaled six mergers & acquisitions and twenty-six financings during the month of May... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-may-2019?hsLang=en) [![Pharma Services May 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services May 2019 Transactions in the Pharma Services – Development industry totaled nine mergers & acquisitions and five financings during the month of... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-may-2019?hsLang=en) [![Pharma Services June 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services June 2019 Medidata Solutions, Inc. was acquired by Dassault Systemes SA for $5.8B ArisGlobal LLC was acquired by Nordic Capital Axio Research,... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-2019?hsLang=en) [![Diagnostics & Tools June 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools June 2019 Blue Earth Diagnostics was acquired by Bracco Imaging for $450M Transplant Genomics was acquired by Eurofins Scientific Singular BIO was... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-june-2019?hsLang=en) [![Diagnostics & Tools July 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools July 2019 Genomic Health was acquired by Exact Sciences BioTek Instruments was acquired by Agilent Technologies Jungla was acquired by Invitae Corporation... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-july-2019?hsLang=en) [![Pharma Services July 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services July 2019 OmniComm Systems to be acquired by Anju Software HistoGeneX was acquired by Arsenal Capital Partners Caprion Proteomics was acquired by... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2019?hsLang=en) [![Diagnostics & Tools August 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools August 2019 Toronto Chemical Research acquired by LGC Limited Keystone Biologics acquired by BioIVT Cytena GmbH acquired by Cellink ProMedDx/GLAS acquired by... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-august-2019?hsLang=en) [![Pharma Services August 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services August 2019 THREAD acquired by Water Street Healthcare Partners, JLL Partners Comprehend Systems acquired by Saama Technologies PharmaSeek acquired by ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-2019?hsLang=en) [![Diagnostics & Tools September 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools September 2019 Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-sept-2019-2?hsLang=en) [![Pharma Services September 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services September 2019 Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-sept-2019-2?hsLang=en) [![Pharma Services October 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services October 2019 eResearchTechnology received an investment from Astorg Partners and Nordic Capital Fund IX Haematologic Technologies was acquired by Edgewater ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-19?hsLang=en) [![Diagnostics & Tools October 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools October 2019 Haematologic Technologies was acquired by Edgewater Capital Partners; Crosstree acted as the financial advisor to Haematologic Technologies Certain ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-october-19?hsLang=en) [![Diagnostics & Tools November 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools November 2019 LGC Ltd. was acquired by Astorg Partners TGR Biosciences/Innova Biosciences/Expedeon were acquired by Abcam Animal Research Models Business Unit of... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-november-2019?hsLang=en) [![Pharma Services November 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services November 2019 LGC Ltd. was acquired by Astorg Partners Centex Studies, Clinical Research of Atlanta, and Okanagan Clinical Trials were acquired by... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-2019?hsLang=en) [![Diagnostics & Tools December 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools December 2019 Hitachi’s Diagnostic Imaging Related Business was acquired by Fujifilm HemaCare was acquired by Charles River Laboratories Biological Industries was ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-december-2019-2?hsLang=en) [![Pharma Services December 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services December 2019 Catalyst Regulatory Services was acquired by Veristat AKESOgen was acquired by Tempus Labs HealthiVibe was acquired by Corrona Core Diagnostics... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-2019-2?hsLang=en) [![Pharma Services January 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services January 2020 Pharma Services – Development Statistics Collaborative acquired by WIRB-Copernicus Group Cunesoft acquired by Phlexglobal Ashfield Pharmacovigilance ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-2020?hsLang=en) [![Diagnostics & Tools January 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools January 2020 Blueprint Genetics acquired by Quest Diagnostics Andrew Alliance to be acquired by Waters Corporation Insight Genetics to be acquired by... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-january-2020?hsLang=en) [![Diagnostics & Tools March 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools March 2020 QIAGEN N.V. to be acquired by Thermo Fisher Scientific Diploid was acquired by Invitae TeraRecon was acquired by SymphonyAI Marker... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-march-2020?hsLang=en) [![Pharma Services March 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services March 2020 Pharma Services  Model Answers was acquired by PAREXEL Richmond Behavioral Associates was acquired by Evolution Research Group (ERG) Genelex was... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-2020?hsLang=en) [![Diagnostics & Tools March 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools March 2020 Partners Group Holding announced it acquisition of Healius Limited Exalenz Biosciences was acquired by Meridian Biosciences Wellbeing Software Group ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-february-2020?hsLang=en) [![Pharma Services March 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services March 2020 Pharma Services  Human Health Biometrics Division of Clindata was acquired by Synteract Pharmacology Capabilities of Excellerate Biosciences was ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-2020?hsLang=en) [![Diagnostics & Tools April 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools April 2020 Celsee was acquired by Bio-Rad Laboratories Luminist Labs acquired by DiscernDx MedGenome raised $55MM from Investors Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-april-2020?hsLang=en) [![Pharma Services April 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services April 2020 Pharma Services  Biotranex was acquired by Frontage Laboratories MedGenome raised $55MM from Investors Perspectum closed $36MM financing round, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-2020?hsLang=en) [![Diagnostics & Tools May 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools May 2020 Stratos Genomics was acquired by Roche Holding AG UrSure was acquired by OraSure Technologies KorvaLabs was acquired by Curative Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-2020?hsLang=en) [![Pharma Services May 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services May 2020 Pharma Services ActiGraph was acquired by ArchiMed Cytapex Bioinformatics was acquired by Insightful Science AbCellera Biologics Closed a $105mm ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-2020?hsLang=en) [![Pharma Services June 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services June 2020 ArcherDx was acquired by Invitae APDM was acquired by ERT TRSS was acquired by EP Mediate Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-2020?hsLang=en) [![Diagnostics & Tools June 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools June 2020 ArcherDx was acquired by Invitae Bluebee Holding BV was acquired by Illumina Mid America Clinical Laboratories was acquired by Quest... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-2020?hsLang=en) [![Pharma Services July 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services July 2020 GlobalCare Clinical Trials was acquired by Covance Vium was acquired by Recursion Pharmaceuticals AIT Biosciences was acquired by Nexelis Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2020?hsLang=en) [![Diagnostics & Tools July 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools July 2020 Brava Diagnostics was acquired by mBio Diagnostics Avanti Polar Lipids was acquired by Croda International The Native Antigen Company was... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-2020?hsLang=en) [![Diagnostics & Tools August 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools August 2020 Ancestory.com was acquired by The Blackstone Group Varian Medical Systems was acquired by Siemens Healthineers Coastal Genomics was acquired by... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-2020?hsLang=en) [![Pharma Services August 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services August 2020 Clinical Ink was acquired by Harvest Partners Ce3 was acquired by Catalyst Clinical Research Comparative Biosciences was acquired by Genesis... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-2020?hsLang=en) [![Pharma Services September 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpeg) ###### Bluebook #### Pharma Services September 2020 Array Biostatistics was acquired by CATO SMS ArchiMed acquired a majority stake in North American Science Associates Within3 closed a... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-2020?hsLang=en) [![Diagnostics & Tools September 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools September 2020 GRAIL was acquired by Illumina Canopy Biosciences was acquired by Bruker Advanced Instruments was acquired by Patricia Industries Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-2020?hsLang=en) [![Diagnostics & Tools October 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools October 2020 Thrive Earlier Detection was acquired by Exact Sciences Base Genomics was acquired by Exact Sciences BIA Separations was acquired by... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-2020?hsLang=en) [![Pharma Services October 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_534465133-3.jpg) ###### Bluebook #### Pharma Services October 2020 Medsavana closed a $15mm round of funding, led by Cathay Innovation Fund Synteract was acquired by Syneos Health Datavant closed... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-2020?hsLang=en) [![Diagnostics & Tools November 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools November 2020 Talis Biomedical Corporation received a $126mm round of funding Change Healthcare sold assets to HealthStream Congenica closed a $51.2mm round... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-2020?hsLang=en) [![Pharma Services November 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_534465133-4.jpg) ###### Bluebook #### Pharma Services November 2020 IntegReview IRB was acquired by Advarra Shanghai Youlin Pharmaceutical Technology closed a $14.9mm round of funding, led by Cenova Ventures... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-2020?hsLang=en) [![Pharma Services December 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_534465133-3.jpg) ###### Bluebook #### Pharma Services December 2020 Trifecta was acquired by WCG Honeywell has agreed to acquire Sparta Systems for $1.3bb Tempus Labs received a $450mm round... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-2020?hsLang=en) [![Diagnostics & Tools December 2020](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools December 2020 Philips has agreed to acquire BioTelemetry for $2.8bb Verily Life Sciences received a $700mm round of funding Everly Well received... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-2020?hsLang=en) [![Diagnostics & Tools January 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpg) ###### Bluebook #### Diagnostics & Tools January 2021 Boston Scientific has agreed to acquire Preventice Solutions for $950mm Thermo Fisher Scientific has agreed to acquire Mesa Biotech for... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-2021?hsLang=en) [![Pharma Services January 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_534465133-3.jpg) ###### Bluebook #### Pharma Services January 2021 Advarra has acquired YourEncore Pfutzner Science & Health Institute was acquired by Diakard Hangzhou Calibra Diagnostics closed a $23mm round... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-2021?hsLang=en) [![Diagnostics & Tools February 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpg) ###### Bluebook #### Diagnostics & Tools February 2021 Veracyte has agreed to acquire Decipher Biosciences for $670mm Exact Sciences Corporation has agreed to acquire Ashion Analytics for $140mm... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-2021?hsLang=en) [![Pharma Services February 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_534465133-3.jpg) ###### Bluebook #### Pharma Services February 2021 ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-2021?hsLang=en) [![Diagnostics & Tools March 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_281211016-1800x1009.jpeg) ###### Bluebook #### Diagnostics & Tools March 2021 Roche has agreed to acquire GenMark Diagnostics for $1.9bb Agilent Technologies has agreed to acquire Resolution Bioscience for approximately ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-2021?hsLang=en) [![Pharma Services March 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_240395963-1-1800x1200.jpeg) ###### Bluebook #### Pharma Services March 2021 ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-2021?hsLang=en) [![Diagnostics & Tools April 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_293953008-1798x1200.jpeg) ###### Bluebook #### Diagnostics & Tools April 2021 The Caryle Group has agreed to acquire Unchained Labs for $435mm DiaSorin has agreed to acquire Luminex for $2bb Avantor... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-2021?hsLang=en) [![Pharma Services April 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_233911676-1800x1200.webp) ###### Bluebook #### Pharma Services April 2021 ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-2021?hsLang=en) [![Pharma Services May 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpg) ###### Bluebook #### Pharma Services May 2021 ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-2021?hsLang=en) [![Diagnostics & Tools May 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_240748820-scaled.jpeg) ###### Bluebook #### Diagnostics & Tools May 2021 CellCarta has acquired Reveal Biosciences NeoGenomics Laboratories has agreed to acquire Inivata for $390mm Caris Life Sciences has received $830mm... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-2021?hsLang=en) [![Pharma Services June 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_201606393-1800x1013.jpeg) ###### Bluebook #### Pharma Services June 2021 Quartesian has been acquired by Summit Partners, 4G Clinical has received $230mm in a round of funding led by Goldman Sachs Asset Management, and ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-2021?hsLang=en) [![Diagnostics & Tools June 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_275264857-1800x1013.webp) ###### Bluebook #### Diagnostics & Tools June 2021 Insilico has received $255mm in a round of funding led by Warburg Pincus,Veracyte has agreed to acquire HalioDx for $318mm, and Docon has agreed to ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-2021?hsLang=en) [![Pharma Services July 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1884612880-B.jpg) ###### Bluebook #### Pharma Services July 2021 OmniSeq has been acquired by LabCorp, VeraSci has been acquired by WCG, and Health Decisions has been acquired by Premier Research. Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2021?hsLang=en) [![Diagnostics & Tools July 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1348356479-A.jpg) ###### Bluebook #### Diagnostics & Tools July 2021 PerkinElmer has agreed to acquire BioLegend $5.25bb, Pacific Biosciences of California has agreed to acquire Omniome for approximately $760mm, and ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-2021?hsLang=en) [![Diagnostics & Tools August 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1351392818-C.jpg) ###### Bluebook #### Diagnostics & Tools August 2021 Thompson Street Capital Partners has agreed to acquire Vector Laboratories for $124mm, Abcam has agreed to acquire BioVision for approximately ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-2021?hsLang=en) [![Pharma Services August 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1351392818-A.jpg) ###### Bluebook #### Pharma Services August 2021 OmniSeq has been acquired by LabCorp, VeraSci has been acquired by WCG, and Health Decisions has been acquired by Premier Research. Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-2021?hsLang=en) [![Diagnostics & Tools September 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_424161376-1800x1135.jpg) ###### Bluebook #### Diagnostics & Tools September 2021 Baxter International has agreed to acquire Hillrom for approximately $12.3bb, Pacific Biosciences has raised $300mm in a round of funding, and ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-2021?hsLang=en) [![Pharma Services September 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1752872030-1800x1200.jpg) ###### Bluebook #### Pharma Services September 2021 Inotiv has agreed to acquire Enivgo for approximately $540mm, Elligo Health Research has acquired ClinEdge, Velocity Clinical Research has acquired ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-2021?hsLang=en) [![Diagnostics & Tools October 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1348356479-B.jpg) ###### Bluebook #### Diagnostics & Tools October 2021 Bio-Rad Laboratories acquired Dropworks for $125mm, Bionano Genomics agreed to acquire BioDiscovery for $100mm, Castle Biosciences agreed to acquire ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-2021?hsLang=en) [![Pharma Services October 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1549204658-scaled.jpg) ###### Bluebook #### Pharma Services October 2021 Flourish Research acquired Excel Medical Clinical, TrialsProPharma acquired Pharmica Consulting, Blackstone agreed to acquire Nucleus Network. Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-2021?hsLang=en) [![Pharma Services November 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_469364276-A.jpg) ###### Bluebook #### Pharma Services November 2021 Cinven has agreed to acquire BioAgilytix, Labcorp has agreed to acquire Toxikon, Lightbeam Health Solutions has acquired CareSignal Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-2021?hsLang=en) [![Diagnostics & Tools November 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_238307387-A.jpg) ###### Bluebook #### Diagnostics & Tools November 2021 Bio-Rad Laboratories acquired Dropworks for $125mm, Bionano Genomics agreed to acquire BioDiscovery for $100mm, Castle Biosciences agreed to acquire ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-2021?hsLang=en) [![Diagnostics & Tools December 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_238307387-B.webp) ###### Bluebook #### Diagnostics & Tools December 2021 Thermo Fisher Scientific acquired PeproTech for $1.85bb, LabCorp has agreed to acquire Personal Genome Diagnostics for $575mm, and Quidel has agreed ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-2021?hsLang=en) [![Pharma Services December 2021](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1014555526-A.jpg) ###### Bluebook #### Pharma Services December 2021 Pharmalex has acquired Pharmasol, Flatiron Health has acquired Protocol First, and Healius has agreed to acquire Agilex Biolabs for $215mm. Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-2021?hsLang=en) [![Diagnostics & Tools January 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_469364276-B.jpg) ###### Bluebook #### Diagnostics & Tools January 2022 PreventionGenetics was acquired by Exact Sciences for $190mm, Sema4 has agreed to acquire GeneDx for approximately $620mm, and Freenome received ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-2022?hsLang=en) [![Pharma Services January 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1348356479-C.jpg) ###### Bluebook #### Pharma Services January 2022 BBK Worldwide was acquired by Publicis Health, Phlexglobal was acquired by PharmaLex, and RealTime Software Solutions has received a strategic ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-2022?hsLang=en) [![Pharma Services February 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1884612880-A.jpg) ###### Bluebook #### Pharma Services February 2022 Definitive Healthcare has acquired Analytical Wizards for $70mm, Velocity Clinical Research has acquired Trier Health, and CenExel Clinical Research ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-2022?hsLang=en) [![Diagnostics & Tools February 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_46595127.jpg) ###### Bluebook #### Diagnostics & Tools February 2022 Becton, Dickinson and Company has acquired Cytognos, Spatial Genomics has received $56mm in a round of funding led by Fulgent Genetics, and Quaero ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-2022?hsLang=en) [![Pharma Services March 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_469364276-A-1.jpg) ###### Bluebook #### Pharma Services March 2022 ConcertAI has raised $150mm in a round of funding led by Sixth Street Partners North American Science Associates has acquired AKRN Scientific ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-2022?hsLang=en) [![Diagnostics & Tools March 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1242847558-768x512.jpg) ###### Bluebook #### Diagnostics & Tools March 2022 Grenova has received funding from Peloton Equity BillionToOne has received $125mm in funding in a round led by Adams Street Partners DNAnexus has ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-2022?hsLang=en) [![Diagnostics & Tools April 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_238307387-C.jpg) ###### Bluebook #### Diagnostics & Tools April 2022 Groupe Bruxelles Lambert (GBL) has agreed to acquire Affidea for approximately $1bb - bioMérieux has agreed to acquire Specific Diagnostics for ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-2022?hsLang=en) [![Pharma Services April 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1054265696_small.jpg) ###### Bluebook #### Pharma Services April 2022 Clarify Health Solutions has raised $165mm in a round of funding led by SoftBank Vision Fund 2 Biofourmis Singapore has raised $300mm in a round of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-2022?hsLang=en) [![Pharma Services May 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1014555526-B.jpg) ###### Bluebook #### Pharma Services May 2022 Novotech has acquired NCGS, CenExel Clinical Research has acquired iResearch Atlanta, Curebase has received $40mm in a round of funding led by ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-2022?hsLang=en) [![Diagnostics & Tools May 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_299056404-A.webp) ###### Bluebook #### Diagnostics & Tools May 2022 Ultima Genomics has received $600mm in a round of funding, GTCR has acquired PathGroup, QIAGEN has agreed to acquire BLIRT Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-2022?hsLang=en) [![Pharma Services June 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1351392818-B.jpg) ###### Bluebook #### Pharma Services June 2022 Advarra, Inc. was acquired by Blackstone Inc., Fujiebio Europe N.V. announced its acquisition of ADx NeuroSciences NV, Florence Healthcare, Inc. ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-2022?hsLang=en) [![Diagnostics and Tools June 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1348356479-D.jpg) ###### Bluebook #### Diagnostics and Tools June 2022 NKT Photonics A/S was acquired by Hamamatsu Photonics K.K., EQT Partners AB, PPD, Inc. announced its acquisition of Envirotainer AB, L7 Informatics, ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-2022?hsLang=en) [![Pharma Services September 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_94798635-1.jpg) ###### Bluebook #### Pharma Services September 2022 iuvo BioScience, LLC was acquired by Ampersand Management LLC, BioIVT has announced its acquisition of XenoTech, LLC, PurpleLab, Inc. closed a $40mm ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-2022?hsLang=en) [![Diagnostics and Tools September 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1348356479-B-1.jpg) ###### Bluebook #### Diagnostics and Tools September 2022 MBio Diagnostics, Inc. was acquired by Heska Corporation (NasdaqCM:HSKA), Biosynex SA (ENXTPA:ALBIO) announced its acquisition of Theradiag SA, ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-2022?hsLang=en) [![Pharma Services October 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/images13.jpg) ###### Bluebook #### Pharma Services October 2022 Cognitive Research Corporation was acquired by River Cities Capital Fund Management AmplifyBio, LLC announced its acquisition of PACT Pharma, Inc. ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-2022?hsLang=en) [![Diagnostics and Tools October 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1351392818-D.jpg) ###### Bluebook #### Diagnostics and Tools October 2022 The Binding Site Group Ltd. was acquired by Thermo Fisher Scientific Inc. (NYSE:TMO), Sebia SA announced its acquisition of Zeus Scientific, Inc., ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-2022?hsLang=en) [![Pharma Services November 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_423930893-C.jpg) ###### Bluebook #### Pharma Services November 2022 Egin Research Ltd was acquired by Velocity Clinical Research Inc., Clarest Health announced its acquisition of CSS Health and Integrity Pharmacy, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-2022?hsLang=en) [![Diagnostics and Tools November 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/shutterstock_1014555526-C.jpg) ###### Bluebook #### Diagnostics and Tools November 2022 Purigen Biosystems, Inc. was acquired by Bionano Genomics, Inc. (NasdaqCM:BNGO), Biocare Medical, LLC announced its acquisition of Empire Genomics, ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-2022?hsLang=en) [![Diagnostics and Tools December 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_356099396-C.jpg) ###### Bluebook #### Diagnostics and Tools December 2022 ACT Genomics Co., Ltd. was acquired by Prenetics Global Limited (NasdaqGM:PRE), Rezolut, LLC announced its acquisition of CNY Diagnostic Imaging ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-2022?hsLang=en) [![Pharma Services December 2022](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_280738306-C.jpg) ###### Bluebook #### Pharma Services December 2022 ACT Genomics Co., Ltd. was acquired by Prenetics Global Limited (NasdaqGM:PRE), Everest Clinical Research Services Inc. announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-2022?hsLang=en) [![Diagnostics and Tools January 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/AdobeStock_356099396-A.webp) ###### Bluebook #### Diagnostics and Tools January 2023 Seven Bridges Genomics Inc., PierianDx, Inc., and UgenTec was acquired by Summa Equity AB, Bayer Aktiengesellschaft (XTRA:BAYN) announced its ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-2023?hsLang=en) [ ###### Bluebook #### Pharma Services January 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-2023?hsLang=en) [ ###### Bluebook #### Pharma Services February 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-2023?hsLang=en) [![Diagnostics and Tools February 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Copy-of-Untitled-Design.png) ###### Bluebook #### Diagnostics and Tools February 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-2023?hsLang=en) [![Pharma Services March 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-1-1.png) ###### Bluebook #### Pharma Services March 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-2023?hsLang=en) [![Diagnostics and Tools March 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Copy-of-Untitled-Design-1.png) ###### Bluebook #### Diagnostics and Tools March 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-2023?hsLang=en) [![Pharma Services April 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Copy-of-Untitled-Design-2.png) ###### Bluebook #### Pharma Services April 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-2023?hsLang=en) [![Diagnostics and Tools April 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-3.png) ###### Bluebook #### Diagnostics and Tools April 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-2023?hsLang=en) [![Pharma Services May 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Copy-of-Untitled-Design-3.png) ###### Bluebook #### Pharma Services May 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-2023?hsLang=en) [![Diagnostics and Tools May 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Copy-of-Untitled-Design-4.png) ###### Bluebook #### Diagnostics and Tools May 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-2023?hsLang=en) [![Diagnostics and Tools June 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-33.png) ###### Bluebook #### Diagnostics and Tools June 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-2023?hsLang=en) [![Pharma Services June 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-34-1.png) ###### Bluebook #### Pharma Services June 2023 Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-2023?hsLang=en) [![Pharma Services July 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/PS-July-BB-Website-Image.png) ###### Bluebook #### Pharma Services July 2023 Highlights from this edition: Genpro Research Inc. was acquired by Catalyst Clinical Research, LLC Alcanza Clinical Research, LLC announced its... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2023?hsLang=en) [![Diagnostics and Tools July 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/DT-July-BB-Website-Image.png) ###### Bluebook #### Diagnostics and Tools July 2023 Highlights from this edition: Quantigen, LLC was acquired by Versiti, Inc. Novacyt UK Holdings Limited announced its acquisition of Yourgene... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-2023?hsLang=en) [![Pharma Services August 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-42.png) ###### Bluebook #### Pharma Services August 2023 Highlights from this edition: Monroe Biomedical Research was acquired by New Harbor Capital Exact Care Pharmacy, LLC announced its acquisition... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-2023?hsLang=en) [![Diagnostics and Tools August 2023](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Untitled-design-43.png) ###### Bluebook #### Diagnostics and Tools August 2023 Highlights from this edition: QDx Pathology was acquired by LabGenomics Experity, Inc. announced its acquisition of OnePacs, LLC Viome, Inc.... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-2023?hsLang=en) [![Pharma Services: Drug Development January 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(64).png) ###### Bluebook #### Pharma Services: Drug Development January 2024 Highlights from this edition: Science 37 Holdings, Inc. was acquired by eMed, LLC, Janvier Labs announced its acquisition of Yecuris, Neocis, In. ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-2024?hsLang=en) [![Diagnostics and Tools January 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(69).png) ###### Bluebook #### Diagnostics and Tools January 2024 Highlights from this edition: Sofie Biosciences, Inc. (25.8% stake) was acquired by Trilantic Capital Management L.P., Roche Diagnostics Corporation ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-2024?hsLang=en) [![Diagnostics and Tools February 2024](https://www.crosstreecapital.com/hubfs/BB%20D%26T%20-%20February%202024.png) ###### Bluebook #### Diagnostics and Tools February 2024 Highlights from this edition: Freenome, Inc. closed a $254MM Series A Financing, led by Roche Diagnostics Corporation, Triple Ring Technologies ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-2024?hsLang=en) [![Pharma Services: Drug Development February 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(1).jpg) ###### Bluebook #### Pharma Services: Drug Development February 2024 Highlights from this edition: Continuum Clinical was acquired by Spectrum Science a Portfolio Company of Knox Lane, Headlands Research announced its ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-2024?hsLang=en) [![Diagnostics and Tools March 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(2)-1.png) ###### Bluebook #### Diagnostics and Tools March 2024 Highlights from this edition: Invicro, LLC was acquired by Calyx Services Inc., Telix Pharmaceuticals Limited (ASX:TLX) announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-2024?hsLang=en) [![Pharma Services: Drug Development March 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(10).png) ###### Bluebook #### Pharma Services: Drug Development March 2024 Highlights from this edition: Endpoint Clinical and Patient Access Businesses of Fortrea was acquired by Arsenal Capital Partners, Calyx Services ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-2024?hsLang=en) [![Diagnostics and Tools April 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(26).png) ###### Bluebook #### Diagnostics and Tools April 2024 Highlights from this edition: Invitae Assets (Genetic Testing) was acquired by Labcorp, Eurofins Scientific SE (ENXTPA:ERF) announced its acquisition ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-2024?hsLang=en) [![Pharma Services: Drug Development April 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(29).png) ###### Bluebook #### Pharma Services: Drug Development April 2024 Highlights from this edition: Creapharm was acquired by Myonex, Windrose Health Investors announced its acquisition of Subject Well, Xaira ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-2024?hsLang=en) [![Pharma Services: Drug Development May 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(42).png) ###### Bluebook #### Pharma Services: Drug Development May 2024 Highlights from this edition: Blackstone Inc. (NYSE:BX) announced its acquisition of I'rom Group Co., Ltd. (TSE:2372), Sift Medical Data, Inc. closed ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-2024?hsLang=en) [![Diagnostics and Tools May 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(43).png) ###### Bluebook #### Diagnostics and Tools May 2024 Highlights from this edition: Invitae was acquired by Labcorp, Quest Diagnostics announced its acquisition of PathAI, Karius, Inc. closed a $100MM ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-2024?hsLang=en) [![Pharma Services: Drug Development June 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(50).png) ###### Bluebook #### Pharma Services: Drug Development June 2024 Highlights from this edition: Pro-Ficiency Holdings was acquired by Simulations Plus, Inc. (NasdaqGS:SLP), Integral Diagnostics Limited (ASX:IDX) ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-2024?hsLang=en) [![Diagnostics and Tools June 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(51).png) ###### Bluebook #### Diagnostics and Tools June 2024 Highlights from this edition: Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners, RareCyte closed a $20MM Growth Financing, ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-2024?hsLang=en) [![Pharma Services: Drug Development July 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-09-05T091738.213.png) ###### Bluebook #### Pharma Services: Drug Development July 2024 Highlights from this edition: BridgeView Life Sciences was acquired by Zensar Technologies, Exima Research Network, LLC announced its acquisition of ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2024-crosstree?hsLang=en) [![Diagnostics and Tools July 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-09-05T092022.185.png) ###### Bluebook #### Diagnostics and Tools July 2024 Highlights from this edition: Eurobio Scientific was acquired by MBK Partners, Astorg announced its acquisition of Hamilton Thorne, CytoReason closed ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-2024?hsLang=en) [![Diagnostics and Tools Blue Book August 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-10-15T150559.010.png) ###### Bluebook #### Diagnostics and Tools Blue Book August 2024 Highlights from this edition: Exscientia was acquired by Recursion, Getinge announced its acquisition of Paragonix, Openwater closed a $100MM Series ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-2024?hsLang=en) [![Pharma Services: Drug Development Blue Book August 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-10-17T145851.189.png) ###### Bluebook #### Pharma Services: Drug Development Blue Book August 2024 Highlights from this edition: Anju was acquired by Valsoft, Vion Biosciences announced its acquisition of Ansh Labs, Ambrosa Biosciences closed a ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-2024?hsLang=en) [![Diagnostics and Tools Blue Book September 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-11-04T164958.577.png) ###### Bluebook #### Diagnostics and Tools Blue Book September 2024 Highlights from this edition: Integrated Oncology Network was acquired by Cardinal Health, Labcorp Holdings Inc. (NYSE:LH) announced its acquisition ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-2024?hsLang=en) [![Pharma Services: Drug Development Blue Book September 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-11-04T165415.322.png) ###### Bluebook #### Pharma Services: Drug Development Blue Book September 2024 Highlights from this edition: Vectura Group was acquired by Molex Asia Holdings, Better Choice Company Inc. (NYSEAM:BTTR) announced its acquisition ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-2024?hsLang=en) [![Diagnostics and Tools Blue Book October 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-11-26T102948.498.png) ###### Bluebook #### Diagnostics and Tools Blue Book October 2024 Highlights from this edition: Nusano closed a $115MM Series A Financing, led by Verily Life Sciences, Section 32, Wasatch Venture Partners, and ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-2024?hsLang=en) [![Pharma Services: Drug Development Blue Book October 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-11-26T103716.855.png) ###### Bluebook #### Pharma Services: Drug Development Blue Book October 2024 Highlights from this edition: Integrated Clinical Trial Services was acquired by Exima Research Network, Synexa Life Sciences announced its ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-2024?hsLang=en) [![Pharma Services: Drug Development Blue Book November 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-12-30T172014.577.png) ###### Bluebook #### Pharma Services: Drug Development Blue Book November 2024 Highlights from this edition: Trial Management Associates was acquired by Headlands Research, TA Associates announced its acquisition of Nexus AG, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-2024?hsLang=en) [![Pharma Services: Drug Supply Chain BlueBook November 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-06T120438.784.png) ###### Bluebook #### Pharma Services: Drug Supply Chain BlueBook November 2024 Highlights from this edition: Avid Bioservices was acquired by Ampersand and GHO Capital, Patrition announced its acquisition of BGM Group, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-november-2024?hsLang=en) [![Pharma Services: Pharmaceutical Commerce BlueBook November 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-06T121211.560.png) ###### Bluebook #### Pharma Services: Pharmaceutical Commerce BlueBook November 2024 Highlights from this edition: BOLDSCIENCE was acquired by Minds + Assembly, Cathay Capital announced its acquisition of Wedia, Writer closed a $200MM ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-november-2024?hsLang=en) [![Diagnostics and Tools BlueBook November 2024](https://www.crosstreecapital.com/hubfs/AdobeStock_982679813.jpeg) ###### Bluebook #### Diagnostics and Tools BlueBook November 2024 Highlights from this edition: Ambry Genetics was acquired by Tempus, TA Associates announced its acquisition of Nexus AG, Sirona Medical closed a ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-november-2024?hsLang=en) [![Diagnostics and Tools BlueBook December 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-21T082215.822.png) ###### Bluebook #### Diagnostics and Tools BlueBook December 2024 Highlights from this edition: Navis Clinical Laboratories was acquired by Wildcat DX, Surgical Science announced its acquisition of Intelligent ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-december-2024?hsLang=en) [![Pharma Services: Pharmaceutical Commerce BlueBook December 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-21T083007.436.png) ###### Bluebook #### Pharma Services: Pharmaceutical Commerce BlueBook December 2024 Highlights from this edition: Realyze Intelligence was acquired by Carta Healthcare, Kester Capital announced its acquisition of Emas Pharma, Cleerly ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-december-2024?hsLang=en) [![Pharma Services: Drug Supply Chain BlueBook December 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-21T083456.357.png) ###### Bluebook #### Pharma Services: Drug Supply Chain BlueBook December 2024 Highlights from this edition: Patterson Companies was acquired by Patient Square Capital, LSL Pharma Group announced its acquisition of Dermolab ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-december-2024?hsLang=en) [![Pharma Services: Drug Development BlueBook December 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-21T093744.809.png) ###### Bluebook #### Pharma Services: Drug Development BlueBook December 2024 Highlights from this edition: Insite Clinical Research was acquired by Adams Clinical, Kester Capital announced its acquisition of Emas Pharma, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-december-2024?hsLang=en) [![Pharma Services: Drug Development BlueBook January 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-02-24T143232.742.png) ###### Bluebook #### Pharma Services: Drug Development BlueBook January 2025 Highlights from this edition: Quartet Health was acquired by NeuroFlow, Suvoda announced its acquisition of Greenphire, Truveta closed a $320MM ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-january-2025?hsLang=en) [![Pharma Services: Drug Supply Chain BlueBook January 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-02-26T112228.581.png) ###### Bluebook #### Pharma Services: Drug Supply Chain BlueBook January 2025 Highlights from this edition: Logility Supply Chain Solutions was acquired by Aptean, Merit CRO announced its acquisition of Ocular Services On ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-january-2025?hsLang=en) [![Pharma Services: Pharmaceutical Commerce BlueBook January 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-02-26T112246.466.png) ###### Bluebook #### Pharma Services: Pharmaceutical Commerce BlueBook January 2025 Highlights from this edition: Upfront Healthcare Services was acquired by Health Catalyst, Sagility announced its acquisition of BroadPath Healthcare ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-january-2025?hsLang=en) [![Diagnostics and Tools BlueBook January 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-02-28T173343.495.png) ###### Bluebook #### Diagnostics and Tools BlueBook January 2025 Highlights from this edition: Akoya Biosciences was acquired by Quanterix, Freeman Capital announced its acquisition of Diesse, Northlane Capital ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-january-2025?hsLang=en) [![Pharma Services: Pharma Technology BlueBook January 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-03T122043.440.png) ###### Bluebook #### Pharma Services: Pharma Technology BlueBook January 2025 Highlights from this edition: Upfront Healthcare Services was acquired by Health Catalyst, Renovaro announced its acquisition of Predictive Oncology, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-january-2025?hsLang=en) [![Diagnostics and Tools BlueBook February 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-26T160124.257.png) ###### Bluebook #### Diagnostics and Tools BlueBook February 2025 Highlights from this edition: Stilla Technologies was acquired by Bio-Rad Laboratories, Rajant Health announced its acquisition of Incite Health, ... Download Now ](https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-february-2025?hsLang=en) [![Pharma Services: Drug Supply Chain BlueBook February 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-26T160935.661.png) ###### Bluebook #### Pharma Services: Drug Supply Chain BlueBook February 2025 Highlights from this edition: Pharmaceutics International was acquired by Jabil, Ionic Partners announced its acquisition of Connexion Technology, ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-february-2025?hsLang=en) [![Pharma Services: Pharmaceutical Commerce BlueBook February 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-26T161312.897.png) ###### Bluebook #### Pharma Services: Pharmaceutical Commerce BlueBook February 2025 Highlights from this edition: 5by5 was acquired by 3LS inc., Cotiviti announced its acquisition of Edifecs, Lumata Health closed a $23MM Series B ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-february-2025?hsLang=en) [![Pharma Services: Pharma Technology BlueBook February 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-31T132859.166.png) ###### Bluebook #### Pharma Services: Pharma Technology BlueBook February 2025 Highlights from this edition: Louvir was acquired by Nuvem Technologies, Pillr Health announced its acquisition of RPh Innovations, Lumata Health ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-february-2025?hsLang=en) [![Pharma Services: Drug Development BlueBook February 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-01T154859.733.png) ###### Bluebook #### Pharma Services: Drug Development BlueBook February 2025 Highlights from this edition: Sigma Healthcare was acquired by CW Group, Amphenol announced its acquisition of LifeSync, Neurocare closed a $20MM ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-february-2025?hsLang=en) [![Pharma Services: Drug Development BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-14T103931.881.png) ###### Bluebook #### Pharma Services: Drug Development BlueBook March 2025 Highlights from this edition: Clinilabs was acquired by InTandem Capital Partners, Kardigan announced its acquisition of Prolaio, Mendel Health ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-march-2025?hsLang=en) [![Pharma Services: Drug Supply Chain BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-16T103632.637.png) ###### Bluebook #### Pharma Services: Drug Supply Chain BlueBook March 2025 Highlights from this edition: Gateway Medical Pharmacy was acquired by Medicure Pharma, RedSail Technologies announced its acquisition of Emporos ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-march-2025?hsLang=en) [![Pharma Services: Pharmaceutical Commerce BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-16T110543.792.png) ###### Bluebook #### Pharma Services: Pharmaceutical Commerce BlueBook March 2025 Highlights from this edition: Mercalis was acquired by PharmaCord, TIS International announced its acquisition of Glidian, Silna Health closed a ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-march-2025?hsLang=en) [![Pharma Services: Pharma Technology BlueBook March 2025](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-04-22T150033.284.png) ###### Bluebook #### Pharma Services: Pharma Technology BlueBook March 2025 Highlights from this edition: Deep 6 AI was acquired by Tempus AI, PharmaCord announced its acquisition of Mercalis, Experiad closed a $27MM Series A ... Download Now ](https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-march-2025?hsLang=en) [![Industry Leaders Panel Discussion: Patient Access Organizations](https://www.crosstreecapital.com/hubfs/Untitled%20(1200%20x%201200%20px)%20(1).png) ###### Videos #### Industry Leaders Panel Discussion: Patient Access Organizations An in-depth panel discussion on the evolution of clinical trial site organizations into  Patient Access Organizations (PAOs), and their growing ... Watch Now ](https://www.crosstreecapital.com/video/industry-leaders-panel-discussion-patient-access-organizations?hsLang=en) [![Precision and Specialty Medicines’ Impact on the Future of Clinical Trials](https://www.crosstreecapital.com/hubfs/theme-crosstree/white-papers/Precision-and-Specialty-Medicine-Clinical-Trial-White-Paper-Cover-Image.jpeg) ###### Whitepaper #### Precision and Specialty Medicines’ Impact on the Future of Clinical Trials Precision and Specialty Medicine are shaping the future of clinical trials. In this white paper, learn how these changes impact the clinical trial ... Learn More ](https://www.crosstreecapital.com/white-paper/precision-and-specialty-medicines-impact-on-the-future-of-clinical-trials?hsLang=en) [![Positioning Biobanking Assets for Maximum Value Leveraging the Precision Medicine Opportunity for Biobanks.](https://www.crosstreecapital.com/hubfs/theme-crosstree/white-papers/Positioning-Biobanking-Assets-for-Maximum-Value-Cover.jpeg) ###### Whitepaper #### Positioning Biobanking Assets for Maximum Value Leveraging the Precision Medicine Opportunity for Biobanks. Precision Medicine offers new opportunities for value creation. In this white paper, learn how to build and adapt inorganic growth strategies for ... Learn More ](https://www.crosstreecapital.com/white-paper/positioning-biobanking-assets-for-maximum-value?hsLang=en) [![Inorganic Growth Strategies in Precision Medicine Forging New Paths to Value Creation in the Future of Healthcare.](https://www.crosstreecapital.com/hubfs/theme-crosstree/white-papers/Inorganic-Growth-Strategies-in-Precision-Medicine-White-Paper-Cover.jpeg) ###### Whitepaper #### Inorganic Growth Strategies in Precision Medicine Forging New Paths to Value Creation in the Future of Healthcare. Precision Medicine offers new opportunities for value creation. In this white paper, learn how to build and adapt inorganic growth strategies for ... Learn More ](https://www.crosstreecapital.com/white-paper/inorganic-growth-strategies-in-precision-medicine?hsLang=en) [![Patient Access Organizations - An Emerging Ecosystem](https://www.crosstreecapital.com/hubfs/Whitepaper%20PAO%20-%20Website%20Thumbnail%20Image.png) ###### Whitepaper #### Patient Access Organizations - An Emerging Ecosystem Welcome to the future of clinical trials, where traditional research sites are evolving into sophisticated Patient Access Organizations (PAOs). Our ... Learn More ](https://www.crosstreecapital.com/white-paper/white-paperpatient-access-organizations-an-emerging-ecosystem?hsLang=en) ###### Deal Insights #### Clinical Pharmacology Associates Acquired by SFBC International August 4, 2003 Crosstree Capital Partners was the exclusive financial advisor for Clinical Pharmacology Associates. Learn More ###### Deal Insights #### Beacon Bioscience Acquired by ICON July 1, 2004 Crosstree Capital Partners served as exclusive financial advisor to Beacon Biosciences. Learn More ###### Deal Insights #### Dynarand acquired by UBC April 21, 2005 Crosstree Capital Partners was the exclusive financial advisor for Dynarand, LLC. Learn More ###### Deal Insights #### Pharmastar acquired by UBC April 21, 2005 Crosstree Capital Partners served as exclusive financial advisor to PharmaStar, LLC. Learn More ###### Deal Insights #### Primus Corporation Acquired by Trinity Biotech July 21, 2005 Crosstree Capital Partners served as exclusive financial advisor to Primus Corporation. Learn More ###### Deal Insights #### Jubilant Organosys Ltd. Acquired Target Research Associates October 5, 2005 Crosstree Capital Partners served as financial advisor to Jubilant Organosys in the transaction. Learn More ###### Deal Insights #### DataLabs acquired Broadpeak November 7, 2005 DataLabs was advised in their acquisition of Broadpeak by Crosstree Capital Partners. Learn More ###### Deal Insights #### InfoPro acquired by Aptuit November 14, 2005 Crosstree Capital Partners was the exclusive financial advisor to InfoPro Solutions. Learn More ###### Deal Insights #### Clintrak acquired by Fisher Scientific International Inc. April 11, 2006 Crosstree Capital Partners was the exclusive financial advisor for Clintrak Pharmaceutical Services. Learn More ###### Deal Insights #### Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006 Crosstree Capital Partners served as exclusive financial advisor to Bridge in the transaction. Learn More ###### Deal Insights #### WorldCare Clinical Acquired by ProScan Imaging June 6, 2006 Crosstree Capital Partners was the exclusive financial advisor for WorldCare Clinical, LLC. Learn More ###### Deal Insights #### BioCor acquired by UBC November 6, 2006 Crosstree Capital served as exclusive financial advisor to BioCor. Learn More ###### Deal Insights #### DataLabs acquired by ClinPhone October 27, 2006 Crosstree Capital served as exclusive financial advisor to DataLabs. Learn More ###### Deal Insights #### Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007 Crosstree Capital Partners was the exclusive financial advisor for Gentiae Clinical Research. Learn More ###### Deal Insights #### Martec acquired by Nostrum December 20, 2006 Crosstree served as exclusive financial advisor to Martec USA. Learn More ###### Deal Insights #### Bridge Laboratories Acquired the Preclinical Testing Division of Gene Logic December 20, 2006 Crosstree Capital Partners served as exclusive financial advisor to Bridge. Learn More ###### Deal Insights #### Medifacts International Acquired by Global Research Services March 23, 2007 Crosstree Capital Partners was the exclusive financial advisor for Medifacts International. Learn More ###### Deal Insights #### CRI Worldwide acquired by SV Life Sciences October 3, 2007 Crosstree Capital Partners served as exclusive financial advisor for CRI Worldwide, Inc. Learn More ###### Deal Insights #### Radiant Research acquired by ICICI Venture June 8, 2007 Crosstree Capital Partners served as financial advisor to Radiant Research. Learn More ###### Deal Insights #### Pacific Data Designs Acquired by DW Healthcare Partners November 6, 2008 Crosstree Capital Partners served as exclusive financial advisor for Pacific Data Designs. Learn More ###### Deal Insights #### Plethico Acquired Natrol December 28, 2007 Financial advisor to Plethico. Learn More ###### Deal Insights #### Micronics raised $6M in Series B Preferred Shares October 16, 2008 Crosstree Capital Partners acted as exclusive financial advisor to Micronics in the transaction. Learn More ###### Deal Insights #### Healthcare Discoveries Acquired by ICON February 11, 2008 Crosstree represented Catalyst Pharma Group / Healthcare Discoveries as the exclusive sell-side banker. Learn More ###### Deal Insights #### Phoenix Data Systems Acquired by Bioclinica (formerly Bio-Imaging Technologies) April 28, 2008 Crosstree Capital Partners served as exclusive financial advisor for Phoenix Data Systems, Inc. Learn More ###### Deal Insights #### PathNet acquired by LabCorp September 28, 2008 Crosstree Capital Partners served as exclusive financial advisor to PathNet. Learn More ###### Deal Insights #### Pharmaceutical Profiles Acquired by Quotient Bioscience December 15, 2008 Crosstree Capital Partners acted as the exclusive financial advisor for Pharmaceutical Profiles Limited. Learn More ###### Deal Insights #### American Diagnostica acquired by SCKISUI March 23, 2009 Crosstree Capital Partners was the exclusive financial advisor to American Diagnostica, Inc. in the transaction. Learn More ###### Deal Insights #### Endpoint received a strategic investment from Chiltern March 31, 2010 Crosstree Capital Partners served as the exclusive financial advisor for Endpoint. Learn More ###### Deal Insights #### Enthalpy Bioanalytical Testing Division Acquired by LabCorp June 11, 2010 Crosstree Capital Partners served as exclusive financial advisor to Enthalpy Analytical. Learn More ###### Deal Insights #### MediSync Acquired by Vyteris April 18, 2011 Financial advisor to MediSync. Learn More ###### Deal Insights #### Synthetech acquired by Grace September 13, 2010 Financial advisor to Synthetech. Learn More ###### Deal Insights #### FirstSource Laboratory Solutions Acquired by LabCorp September 14, 2010 Crosstree Capital Partners served as exclusive financial advisor to FirstSource Laboratory Solutions. Learn More ###### Deal Insights #### DMD Acquired by Aptilon September 18, 2009 Financial advisor to DMD. Learn More ###### Deal Insights #### CentralCoast Pathology laboratory business acquired by Sonic Healthcare February 7, 2011 Crosstree Capital Partners acted as exclusive financial advisor to CCPC in the transaction. Learn More ###### Deal Insights #### Arrowhead acquired by MedCo July 28, 2011 Crosstree Capital Partners acted as exclusive financial advisor to Arrowhead in the transaction. Learn More ###### Deal Insights #### MDCI Acquired by Aptiv Solutions and SV Life Sciences August 22, 2011 Crosstree Capital Partners served as exclusive financial advisor to MDCI. Learn More ###### Deal Insights #### Mediatech Acquired by Corning December 1, 2011 Overview Corning Incorporated (NYSE: GLW) announced that it has completed the acquisition of Mediatech, Inc., a Virginia-based corporation, including ... Learn More ###### Deal Insights #### Biomain Acquired by Heraeus March 1, 2012 Financial advisor to Biomain. Learn More ###### Deal Insights #### invivodata Acquired by ERT and Genstar Capital, LLC July 9, 2012 Crosstree Capital initiated and closed this transaction as exclusive financial advisor to invivodata. Learn More ###### Deal Insights #### Paragon Biomedical acquired by Clinipace WorldWide September 25, 2012 Crosstree Capital Partners served as Paragon's investment banker and financial advisor. Learn More ###### Deal Insights #### Predictive Biosciences anatomic pathology business acquired by Miraca Life Sciences November 19, 2012 Crosstree Capital Partners served as exclusive financial advisor to Predictive Biosciences. Learn More ###### Deal Insights #### Pacific Physicians Laboratory, Inc. Acquired by LabCorp December 11, 2012 Overview On December 11, 2012, Crosstree Capital Partners announced the sale of Pacific Physicians Laboratory, Inc. In Lynnwood, Washington to ... Learn More ###### Deal Insights #### Cytolab Pathology Services Acquired by LabCorp December 11, 2012 Crosstree Capital Partners served as exclusive financial advisor to Cytolab Pathology Services. Learn More ###### Deal Insights #### IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013 Crosstree Capital Partners served as exclusive financial advisor to ClinStar. Learn More ###### Deal Insights #### IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013 Overview PRA, a leading clinical research, announced it has acquired privately held ClinStar, LLC, a clinical research organization managing Phase ... Learn More ###### Deal Insights #### BioAgilytix Labs Acquired by Riverside Partners June 4, 2013 Crosstree Capital Partners served as exclusive financial advisor to BioAgilytix Labs. Learn More ###### Deal Insights #### Critical Path Service Acquired by Knoell June 13, 2013 Crosstree Capital Partners served as exclusive financial advisor to CPS. Learn More ###### Deal Insights #### Converge acquired by Quest Diagnostics October 7, 2013 Crosstree Capital Partners served as exclusive financial advisor to Water Street and ConVerge. Learn More ###### Deal Insights #### Ancora acquired by Corden Pharma November 12, 2013 Financial advisor to Ancora. Learn More ###### Deal Insights #### Accelrys Acquired QUMAS December 9, 2013 Financial advisor to Accelrys. Learn More ###### Deal Insights #### TTM Acquired by Indegene January 2, 2014 Financial advisor to TTM. Learn More ###### Deal Insights #### Gentris acquired by Cancer Genetics July 21, 2014 Crosstree Capital Partners served as exclusive financial advisor to Gentris. Learn More ###### Deal Insights #### Fountain Medical Development (FMD) merged with K&L consulting services September 1, 2014 Crosstree served as the exclusive financial advisor to Fountain Medical Development. Learn More ###### Deal Insights #### Durbin acquired Pharmaceutical Trade Services, Inc. (PTSI) December 1, 2014 Financial advisor to Durbin. Learn More ###### Deal Insights #### ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014 Crosstree Capital Partners represented ePS in its transaction with WCG. Learn More ###### Deal Insights #### Focus Pharmaceuticals Ltd. Acquired by AMCo October 1, 2014 Financial and strategic advisor to Focus Pharmaceuticals. Learn More ###### Deal Insights #### PHT acquired by ERT and Genstar Capital May 11, 2015 Crosstree Capital Partners served as PHT's exclusive financial advisor. Learn More ###### Deal Insights #### Cliniqa acquired by Bio-Techne July 9, 2015 Crosstree Capital Partners served as exclusive financial advisor to Cliniqa Corporation. Learn More ###### Deal Insights #### ILS Genomics Acquired by LabCorp July 31, 2015 Crosstree Capital Partners served as exclusive financial advisor to Integrated Laboratory Systems, Inc., parent of ILS Genomics. Learn More ###### Deal Insights #### Baylor College of Medicine (BDC) assets acquired by Cell Medica June 17, 2016 Financial advisor to Baylor College of Medicine. Learn More ###### Deal Insights #### Mo Bio acquired by Qiagen January 11, 2016 Crosstree Capital Partners acted as exclusive financial advisor to MO BIO. Learn More ###### Deal Insights #### Ducere Pharma acquired by Dr. Reddy’s May 25, 2016 Financial advisor to Ducere Pharma. Learn More ###### Deal Insights #### Clinical Pharmacology of Miami acquired by Evolution Research Group Crosstree Capital Partners served as exclusive financial advisor to CPMI. Learn More ###### Deal Insights #### GQ Life Sciences acquired by Aptean October 3, 2016 Financial advisor to GQ Life Sciences. Learn More ###### Deal Insights #### ProPhase acquired by WCG and Arsenal Capital Partners May 9, 2017 Overview WIRB-Copernicus Group (WCGTM) announced its acquisition of MedAvante and ProPhase. WCG is the leading provider of solutions that improve the ... Learn More ###### Deal Insights #### Tulip Group acquired by PerkinElmer January 9, 2017 Financial advisor to Tulip Group. Learn More ###### Deal Insights #### IDT acquired the Oligo Manufacturing Business of GeneWorks February 8, 2017 Crosstree Capital Partners initiated this transaction on behalf of IDT. Learn More ###### Deal Insights #### MedAvante acquired by Arsenal Capital Partners and WCG May 9, 2017 Crosstree Capital Partners acted as exclusive financial advisor to MedAvante. Learn More ###### Deal Insights #### Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017 Financial advisor to Chemical Computing Group. Learn More ###### Deal Insights #### Access Regional Laboratory Business acquired by LabCorp June, 2017 Crosstree Capital Partners acted as exclusive financial advisor to Access. Learn More ###### Deal Insights #### OmniSeq Received a Strategic Investment from LabCorp August 21, 2017 Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq Inc. Learn More ###### Deal Insights #### Trevigen acquired by Bio-Techne September 5, 2017 Crosstree Capital Partners acted as exclusive financial advisor to Trevigen. Learn More ###### Deal Insights #### Research Point Global acquired by WuXi AppTec October 17, 2017 Crosstree Capital Partners acted as exclusive financial advisor to ResearchPoint Global (RPG). Learn More ###### Deal Insights #### mProve Health acquired by Bracket October 24, 2017 Crosstree Capital Partners served as exclusive financial advisor to mProve. Learn More ###### Deal Insights #### Xenometrics acquired by CitoxLab October 31, 2017 Crosstree Capital Partners served as exclusive financial advisor to Xenometrics. Learn More ###### Deal Insights #### Citoxlab acquired Solvo Biotechnology March 12, 2018 Crosstree Capital Partners acted as exclusive financial advisor to Citoxlab. Learn More ###### Deal Insights #### MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018 Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics. Learn More ###### Deal Insights #### OmniSeq Received a Strategic Investment from HITACHI April 12, 2018 Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq. Learn More ###### Deal Insights #### mPulse Mobile Acquired Message Beam June 2018 Crosstree Capital Partners was the exclusive financial advisor for mPulse. Learn More ###### Deal Insights #### Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018 Overview Santus Laboratories (owned by HealthEdge Partners) manufactures and sells dermatology products to the institutional market, including ... Learn More ###### Deal Insights #### CareMetx (owned by The Vistria Group) acquired VirMedica (owned by Petra Capital Partners) September 2018 Overview CareMetx, a technology-enabled hub services and provider for pharmaceutical and biotechnology manufacturers, announced its acquisition of ... Learn More ###### Deal Insights #### PhenoPath has been acquired by Quest Diagnostics September 2018 Overview Quest Diagnostics announced the acquisition of PhenoPath, a national provider of specialized anatomic pathology and related services. ... Learn More ###### Deal Insights #### CSM (a portfolio company of Great Point Partners) has been acquired by Clinigen September 2018 Overview Clinigen Group announced the acquisition of Clinical Supplies Management (“CSM”), a specialist provider of packaging, labeling, warehousing ... Learn More ###### Deal Insights #### Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza Overview Transposagen Biopharmaceuticals, Inc. (“Transposagen”) is a leader in gene editing and integration technologies and services with ... Learn More ###### Deal Insights #### Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018 Overview Santus Laboratories (owned by HealthEdge Partners) manufactures and sells dermatology products to the institutional market, including ... Learn More ###### Deal Insights #### PMI Preclinical was acquired by Covance, a subsidiary of LabCorp October 2018 Overview Covance, the drug and medical device development subsidiary of LabCorp, acquired PMI Preclinical on October 29, 2018. PMI Preclinical is a ... Learn More ###### Deal Insights #### Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018 Overview Biorasi, LLC announced the completion of a majority investment by Riordan, Lewis & Haden Equity Partners (“RLH”) on November 16, 2018. ... Learn More ###### Deal Insights #### GSK Sold Assets to Crown Laboratories Overview GlaxoSmithKline PLC (GSK) is a global pharmaceutical development, manufacturing, and marketing company. GSK sold five branded assets to ... Learn More ###### Deal Insights #### Velos acquired by WCG, a portfolio company of Arsenal Capital Partners Overview WIRB-Copernicus Group (WCG), the leading provider of tech-enabled solutions that improve the quality and efficiency of clinical research, ... Learn More ###### Deal Insights #### MolecularMD has been acquired by ICON Plc. Overview ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced ... Learn More ###### Deal Insights #### DataCeutics has been acquired by Navitas Life Sciences, a TAKE Solutions Company Overview Navitas Life Sciences, a subsidiary of TAKE Solutions, announced its acquisition of DataCeutics, a provider of statistical data management ... Learn More ###### Deal Insights #### Genstar Capital acquires Advarra from Linden Partners Overview On June 6, 2019, Genstar Capital announced that it signed a definitive agreement to acquire Advarra from Linden Capital Partners. Advarra, ... Learn More ###### Deal Insights #### Anju Software acquires OmniComm Systems Overview On July 16, 2019, OmniComm Systems (OTCQX: OMCM) announced that it entered into a merger agreement with Anju Software. OmniComm is a ... Learn More ###### Deal Insights #### HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners Overview On July 31, 2019, HistoGeneX and Caprion Biosciences announced they have agreed to combine their respective businesses. This combination ... Learn More ###### Deal Insights #### Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses Overview On September 4, 2019, OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and ... Learn More ###### Deal Insights #### Perrigo Advances Consumer Strategy with Acquisition of Prevacid®24HR from GSK Overview On September 4, 2019, Perrigo acquired branded rights to Prevacid® from GlaxoSmithKline. Under the terms of the agreement, Perrigo will have ... Learn More ###### Deal Insights #### Chonometriq Received an Investment from Full In Partners October 1, 2019 Overview Chronometriq, founded in 2012, is a leader in digital healthcare management through its suite of products enabling full-cycle appointment ... Learn More ###### Deal Insights #### Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners Overview On October 11, 2019, Edgewater Capital Partners announced they have entered into an agreement to acquire Haematologic Technologies ... Learn More ###### Deal Insights #### WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P. Overview On November 14, 2019, Leonard Green & Partners, L.P. (“LGP”), in partnership with Arsenal Capital Partners (“Arsenal”) and Novo Holdings ... Learn More ###### Deal Insights #### GSK is selling assets to Foundation Consumer Healthcare Overview Foundation Consumer Healthcare owned by Kelso Private Equity and Juggernaut Capital, has entered into an agreement to acquire seven branded ... Learn More [![Array Biostatistics was acquired by CATO SMS](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/crosstree-tombstone-infographic-thumbnail-2.png) ###### Deal Insights #### Array Biostatistics was acquired by CATO SMS Overview CATO SMS has acquired Wilmington, NC-based Array Biostatistics to expand its offering of specialized clinical research solutions. ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Deal-Insights_Array-Biostatistics-_9-24-20_VF.pdf?hsLang=en) [![IntegReview was acquired by Advarra](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_IRB_Infographic_vF.png) ###### Deal Insights #### IntegReview was acquired by Advarra Overview Advarra has acquired Austin-based IntegReview and will integrate its early-phase-focused, specialized IRB solutions into a center of ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-IRB-Deal-Insights-IntegReview-Advarra.pdf?hsLang=en) [![Trifecta Clinical was acquired by WCG](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/deal.png) ###### Deal Insights #### Trifecta Clinical was acquired by WCG Overview WCG has acquired Los Angeles-based Trifecta Clinical to bolster its remote study startup and compliance support offerings. Significance WCG ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Training_FactSheet_12-4-20_VF.pdf?hsLang=en) [![dMed Merged with Clinipace](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_dMed_Infographic-v3-scaled.jpg) ###### Deal Insights #### dMed Merged with Clinipace China-based dMed has acquired global CRO Clinipace to provide turnkey, end-to-end development support to clients in any market in the world. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_dMed_FactSheet.pdf?hsLang=en) [![Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstre_Tombstone_Infographic_Pyxant_Labcorp-2.png) ###### Deal Insights #### Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site Innovative bioanalytical CRO Pyxant Labs acquired assets from Covance by Labcorp to strengthen Pyxant’s business with enhanced capabilities in large ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Deal_Insight_Overview_Pyxant_Labcorp_Archimed.pdf?hsLang=en) [![Quartesian Acquired by Summit Partners to Form New Global Outsourced Medtech Provider](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Quartesian_Summit-scaled.jpg) ###### Deal Insights #### Quartesian Acquired by Summit Partners to Form New Global Outsourced Medtech Provider Global independent biometrics company, Quartesian, acquired by Summit Partners to form key pillar of newly established global outsourced medtech ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Deal_Insight_Overview_Quartesian-1.pdf?hsLang=en) [![Clinical Trials of Texas Recapitalized by NMS Capital to Form new Flourish Research Clinical Research Site Platform](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_CTT-scaled.jpg) ###### Deal Insights #### Clinical Trials of Texas Recapitalized by NMS Capital to Form new Flourish Research Clinical Research Site Platform Clinical Trials of Texas has been recapitalized by NMS Capital to form the new Flourish Research clinical research site platform, to become a ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Clinical-Trials-of-TX_FactSheet_v2.pdf?hsLang=en) [![ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_ZebraSci-2-scaled.jpg) ###### Deal Insights #### ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities Leading global medical technology manufacturer BD has acquired device development, manufacturing, and testing company ZebraSci to enhance drug-device ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_ZebraSci_FactSheet.pdf?hsLang=en) [![Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Pharmica-scaled.jpg) ###### Deal Insights #### Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise Pharmica Consulting was acquired by ProPharma Group to provide end-to-end clinical trial execution solutions to pharma, biotech, and medical device ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Pharmica_FactSheet.pdf?hsLang=en) [![Flourish Research Acquires Excel Medical Clinical Trials to Expand Site Network and Therapeutic Expertise](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Excel.png) ###### Deal Insights #### Flourish Research Acquires Excel Medical Clinical Trials to Expand Site Network and Therapeutic Expertise Excel’s site location, therapeutic areas of focus, and expertise made them the ideal addition to Flourish Research’s growing platform, which will ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Excel_FactSheet_Final.pdf?hsLang=en) [![UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_UpStream-1.jpg) ###### Deal Insights #### UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults UpStream Care’s unique model offers support to practices of any size looking to participate in value-based care models. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_UpStream_FactSheet.pdf?hsLang=en) [![pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Pharmasol-smaller.jpg) ###### Deal Insights #### pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions pharmasol’s pharmacovigilance solutions provide automated data management, warehousing, and reporting, making their technology the perfect complement ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Pharmasol_FactSheet.pdf?hsLang=en) [![Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Protocol-First_Infographic-01-1-scaled.jpg) ###### Deal Insights #### Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research Protocol First’s leading-edge technology and focus on complex oncological studies made them the perfect strategic fit for Flatiron, the leader in ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Protocol-First_FactSheet.pdf?hsLang=en) [![PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/PreventionGenetics-Infographic.png) ###### Deal Insights #### PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing PreventionGeneticsis the perfect complement to Exact Sciences’ advanced cancer diagnostics portfolio and supports its entrance into hereditary cancer ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_PreventionGenetics_FactSheet.pdf?hsLang=en) [![BBK Worldwide Acquired by Publicis Health to Expand Clinical Trial Expertise with Proprietary Technology and Patient-Centric Solutions](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/BBK-Infographic.png) ###### Deal Insights #### BBK Worldwide Acquired by Publicis Health to Expand Clinical Trial Expertise with Proprietary Technology and Patient-Centric Solutions By bringing together BBK's proprietary technology and methodologies and Langland's award-winning creative capabilities under one roof, Publicis ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_BBK_FactSheet.pdf?hsLang=en) [![RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree-Deal-Insight-Infographic-Featured-Image-RealTime.png) ###### Deal Insights #### RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation RealTime's company’s leadership position in the clinical research technology market made it the perfect investment opportunity for LLR Partners. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_RealTime_FactSheet-v2.pdf?hsLang=en) [![BCT Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/BCT-Deal-Infographic-Featured-Image.png) ###### Deal Insights #### BCT Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research Boston Clinical Trials has been recapitalized by Martis Capital via its newly formed clinical research site platform, Alcanza Clinical Research. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_BCT_FactSheet.pdf?hsLang=en) [![Ascent and PharmaLex Merge to Expand Clinical Development Services in Asia](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Ascent-Pharmalex.png) ###### Deal Insights #### Ascent and PharmaLex Merge to Expand Clinical Development Services in Asia Ascent's expertise and pan-Asian infrastructure made it the perfect complement to PharmaLex’s broad CRO services portfolio and existing US and EU ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Ascent_FactSheet.pdf?hsLang=en) [![CCRC Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_CCRC-01.jpg) ###### Deal Insights #### CCRC Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research Coastal Carolina Research Center has been recapitalized by Martis Capital via its newly formed clinical research site platform, Alcanza Clinical ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_CCRC_FactSheet_Final.pdf?hsLang=en) [![Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Grenova-Infographic-Image.png) ###### Deal Insights #### Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives Growth recapitalization will enable Grenova to accelerate its sales and marketing efforts, launch additional products, and build out its presence ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Grenova_FactSheet.pdf?hsLang=en) [![Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Lexitas-NovaQuest-Deal-Infographic_Final.png) ###### Deal Insights #### Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Lexitas_FactSheet_Final.pdf?hsLang=en) [![H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Navitas_Infographic-v2-featured-image-1.png) ###### Deal Insights #### H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Navitas_FactSheet-v2.pdf?hsLang=en) [![Sabai Global Acquired by Thompson Street Capital Partners to Accelerate IBC and IRB Growth](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Sabai-Infographic_featured-image.png) ###### Deal Insights #### Sabai Global Acquired by Thompson Street Capital Partners to Accelerate IBC and IRB Growth Sabai's specialized services made the Company the ideal target for a strategic growth investment from Thompson Street Capital Partners. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Sabai_FactSheet.pdf?hsLang=en) [![LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/LVC-and-Summit-Infographic-Featured-Image.png) ###### Deal Insights #### LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth LongueVue Capital Partners has acquired a majority stake in Summit Clinical Research to accelerate SMO/IRO growth. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_LVC-Summit_FactSheet_Final.pdf?hsLang=en) [![RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/RMC-Deal-Infographic-Featured-Image.png) ###### Deal Insights #### RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_RMC_Syner-G_FactSheet.pdf?hsLang=en) ###### Deal Insights #### Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities Boca’s high growth profile and differentiated positioning within the biobanking industry made it the ideal acquisition for Clairvest’s ongoing ... Learn More [![OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Open-Clinica_Infographic-1.png) ###### Deal Insights #### OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_OpenClinica_FactSheet.pdf?hsLang=en) [![anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Anteris-featured-image.png) ###### Deal Insights #### anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally Transaction helps both companies realize their shared goals of geographic expansion, while also bolstering service capabilities. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-Deal-Insight-Campaign-One-Pager-Anteris.pdf?hsLang=en) [![ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_ClinChoice-01.png) ###### Deal Insights #### ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Deal-Insight-One-pager-Clinchoice-CROMSOURCE.pdf?hsLang=en) [![Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/CSSi-PAG-Infographic-featured-image.png) ###### Deal Insights #### Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities Clinical Site Services and Patient Advertising Guru were acquired by American Clinical Research Services to add tech-enabled patient recruitment ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_CSSi_FactSheet.pdf?hsLang=en) [![Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Benchmark-v2-2.png) ###### Deal Insights #### Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree_Benchmark_FactSheet-v2.pdf?hsLang=en) [![Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Untitled-design-22.png) ###### Deal Insights #### Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America Access Medical Labs has allied with Grupo Diagnostico Aries to expand their diagnostic lab capabilities into North America. Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Deal-Insight-One-pager-Access-Medical-Labs-2.pdf?hsLang=en) [![Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Infographic-Versiti.png) ###### Deal Insights #### Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Deal-Insights-One-Pager-Versiti-Final.pdf?hsLang=en) [![Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Benchmark.png) ###### Deal Insights #### Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-Deal-Insights-One-Pager-AccelAlcanza-Final.pdf?hsLang=en) [![Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Catalyst-Genpro.png) ###### Deal Insights #### Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings Catalyst Clinical Research, a portfolio company of QHP Capital, acquired Genpro Research to expand global footprint and deepen service offerings Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-Deal-Insights-One-Pager-CatalystGenpro-FINAL.pdf?hsLang=en) [![QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Infographic-QDx-Social-Sized.png) ###### Deal Insights #### QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Deal-Insights-One-Pager-QDx-Pathology-Final.pdf?hsLang=en) [![SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Infographic-SSI-Strategy-Social-Sized.png) ###### Deal Insights #### SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-Deal-Insights-One-Pager-SSI-Strategy-NDA-Group-AB-FINAL.pdf?hsLang=en) [![Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Infographic-MBR-Social-Sized-1.png) ###### Deal Insights #### Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Deal-Insights-One-Pager-Monroe-Biomedical-Research-Final.pdf?hsLang=en) [![Grant Avenue Capital Recapitalizes CREO](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Infographic-GrantCREO-Social-Sized.png) ###### Deal Insights #### Grant Avenue Capital Recapitalizes CREO Overview Grant Avenue Capital has recapitalized CREO Inc. Significance The life sciences consulting industry is witnessing a dynamic shift as it ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-Deal-Insights-One-Pager-Grant-Avenue-CREO.V2.pdf?hsLang=en) [![VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Infographic-VaxTRIALS-Social-Sized.png) ###### Deal Insights #### VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities Overview VaxTRIALS has been acquired by Emmes, a portfolio company of New Mountain Capital, to add a new Latin America base and vaccine research ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree-Deal-Insights-One-Pager-VaxTRIALS.V3.pdf?hsLang=en) [![Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Infographic-Versiti-Pearl-Pathways-Social-Sized.png) ###### Deal Insights #### Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities Overview Versiti has acquired Pearl Pathways to strengthen their existing IRB foothold and ability to offer broader regulatory support for clinical ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Deal-Insights-One-Pager-Versiti-Pearl-Pathways.pdf?hsLang=en) ###### Deal Insights #### Romark Laboratories Amount Raised Undisclosed Romark Laboratories Amount Raised Undisclosed Learn More ###### Deal Insights #### Digital Healthcare Raised $3,000,000 Preferred Stock through a Placement Agent Digital Healthcare Raised $3,000,000 Preferred Stock through a Placement Agent Learn More ###### Deal Insights #### Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent Learn More ###### Deal Insights #### ProstaLund Acquired by Farstorp ProstaLund Acquired by Farstorp Learn More ###### Deal Insights #### Chemo assets acquired by Ducere Pharma Chemo assets acquired by Ducere Pharma Learn More ###### Deal Insights #### HCS acquired by Girling HCS acquired by Girling Learn More ###### Deal Insights #### Semorex acquired by MYOS corporation Semorex acquired by MYOS corporation Learn More ###### Deal Insights #### Senova Systems Acquired by Parker Senova Systems Acquired by Parker Learn More ###### Deal Insights #### Medsphere Raised $12,000,000 of Senior Debt Medsphere Raised $12,000,000 of Senior Debt Learn More ###### Deal Insights #### Viactiv acquired by ADARE and TPG Viactiv acquired by ADARE and TPG Learn More ###### Deal Insights #### SunLink Sold Assets to CVS Health SunLink Sold Assets to CVS Health Learn More ###### Deal Insights #### PBI Financial Advisory PBI Financial Advisory Learn More ###### Deal Insights #### Imedex Acquired by AmerisourceBergen May 10, 2004 Imedex Acquired by AmerisourceBergen May 10, 2004 Learn More ###### Deal Insights #### Ixion Biotechnology Inc. Financial advisory Ixion Biotechnology Inc. Financial advisory Learn More ###### Deal Insights #### Atherotech Financial Advisory Atherotech Financial Advisory Learn More ###### Deal Insights #### Candescent Healing Acquired by Candescent Partners Candescent Healing Acquired by Candescent Partners Learn More ###### Deal Insights #### CMDX Financial Advisory CMDX Financial Advisory Learn More ###### Deal Insights #### Aptilon acquired by Indegene November 9, 2012 Aptilon acquired by Indegene November 9, 2012 Learn More ###### Deal Insights #### SigmaCare acquired by Homecare CRM March 10, 2015 SigmaCare acquired by Homecare CRM March 10, 2015 Learn More ###### Deal Insights #### DrugDev Acquired by QuintilesIMS DrugDev Acquired by QuintilesIMS Learn More ###### Deal Insights #### Pyxant Labs Receives Majority Investment from ArchiMed Pyxant Labs Receives Majority Investment from ArchiMed Learn More [![Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Thumbnail%20Alpha%20IRB%20Deal%20Insight.png) ###### Deal Insights #### Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Alpha%20IRB%20+%20Sabai%20Global.pdf?hsLang=en) ###### Deal Insights #### A&J Home Care, Inc. Acquired by HCS A&J Home Care, Inc. Acquired by HCS Learn More ###### Deal Insights #### Biosafe Raised $6,500,000 Subordinated Debt Through a Placement Agent Biosafe Raised $6,500,000 Subordinated Debt Through a Placement Agent Learn More ###### Deal Insights #### GSK sold assets to Lil’ Drug Store GSK sold assets to Lil’ Drug Store Learn More ###### Deal Insights #### GSK Sold Assets to COMBE GSK Sold Assets to COMBE Learn More ###### Deal Insights #### Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise Learn More ###### Deal Insights #### NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent Learn More [![Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Thumbnail%20Modular%20Devices%20Deal%20Insight.png) ###### Deal Insights #### Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Modular%20Devices%20+%20Flow%20Clean%20Rooms%20and%20Supply%20(Final).pdf?hsLang=en) [![Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Thumbnail%20Yecuris%20Deal%20Insight.png) ###### Deal Insights #### Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Yecuris%20+%20Janvier%20Labs%20(NEW).pdf?hsLang=en) [![Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/insights/Thumbnail%20Continuum%20Clinical%20Deal%20Insight.png) ###### Deal Insights #### Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Continuum%20Clinical%20+%20Spectrum%20Science.pdf?hsLang=en) [![physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(72).png) ###### Deal Insights #### physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20physIQ%20+%20Prolaio.pdf?hsLang=en) [![Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(46)-1.png) ###### Deal Insights #### Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Calyx%20+%20Ennov.pdf?hsLang=en) [![Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(4)-1.png) ###### Deal Insights #### Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Myonex%20+%20SaveWay.pdf?hsLang=en) [![Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(19)-1.png) ###### Deal Insights #### Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20Myonex%20+%20Creapharm.pdf?hsLang=en) [![BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(40).png) ###### Deal Insights #### BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20BBI%20+%20IBEX.pdf?hsLang=en) [![Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(48).png) ###### Deal Insights #### Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20LVC%20+%20Kerwin.pdf?hsLang=en) [![Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(49).png) ###### Deal Insights #### Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20LVC%20+%20CRCNJ.pdf?hsLang=en) [![Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-09-04T092707.128.png) ###### Deal Insights #### Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20Anju%20Software%20+%20Valsoft.pdf?hsLang=en) [![Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-07T163307.697.png) ###### Deal Insights #### Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business Actigraph, a Portfolio Company of Archimed, acquired Biofourmis Connect, a Division of Biofourmis, to Establish a Software and Data Ecosystem for ... Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20ActiGraph%20+%20Biofourmis.pdf?hsLang=en) [![Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(1).png) ###### Deal Insights #### Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20Bio-Techne%20+%20GeminiBio.pdf?hsLang=en) [![Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-28T163243.240.png) ###### Deal Insights #### Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20Sengenics%20+%20Standard%20BioTools.pdf?hsLang=en) [![Deep 6 AI Acquired by Tempus](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-13T113514.444.png) ###### Deal Insights #### Deep 6 AI Acquired by Tempus  Deep 6 AI Acquired by Tempus  Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20Deep%206%20AI%20+%20Tempus.pdf?hsLang=en) [![IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-03-17T150049.946.png) ###### Deal Insights #### IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates Learn More ](https://www.crosstreecapital.com/hubfs/theme-crosstree/pdf/Crosstree%20Deal%20Insights%20One-Pager%20-%20IPeople%20+%20RLDatix.pdf?hsLang=en) [![ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt](https://www.crosstreecapital.com/hubfs/ROI%20Healthcare%20Deal%20Featured%20Image%20(1).png) ###### Deal Insights #### ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt Learn More ](https://www.crosstreecapital.com/hubfs/ROI%20Deal%20Announcement.pdf?hsLang=en) [![Surfing the Wave: The Patient-Data Puzzle](https://www.crosstreecapital.com/hubfs/Insights/Articles/NewArticle-2.png) ###### Articles #### Surfing the Wave: The Patient-Data Puzzle As technology continues to rapidly evolve, opportunities for pharma also increase when it comes to patient data. The existence of information is not ... Learn More ](https://www.crosstreecapital.com/article/surfing-the-wave-the-patient-data-puzzle?hsLang=en) [![Crosstree Helps ArchiMed Create Early Drug Development Platform Through Three-way Acquisition](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpg) ###### Case Study #### Crosstree Helps ArchiMed Create Early Drug Development Platform Through Three-way Acquisition Recognizing the emerging opportunity of Precision Medicine, ArchiMed engaged Crosstree to help develop and execute its growth strategy in the early ... Learn More ](https://www.crosstreecapital.com/case-study/crosstree-helps-archimed-create-early-drug-development-platform-through-three-way-acquisition?hsLang=en) [![Innovations in Pharmaceutical Development™](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpg) ###### Market Map #### Innovations in Pharmaceutical Development™ Introducing Innovations in Pharmaceutical Development™ In this first-of-its-kind book, Crosstree profiles over 50 of the most innovative companies ... Learn More ](https://www.crosstreecapital.com/market-map/innovations-in-pharmaceutical-development?hsLang=en) [![Innovation’s Role in Life Sciences with Rick Riegel](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/Rick-Riegel-Still-2.png) ###### Videos #### Innovation’s Role in Life Sciences with Rick Riegel Rick Riegel, Panelist for Crosstree's Innovations in Pharmaceutical Development, discusses the role of innovation in the Life Sciences industry. Learn More ](https://www.crosstreecapital.com/videos/innovations-role-in-life-sciences-with-rick-riegel?hsLang=en) [![Global Connectivity and Pharma Development Innovation with Steve Gens](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/Steve-Gens-still-2.png) ###### Videos #### Global Connectivity and Pharma Development Innovation with Steve Gens Steve Gens, profiled in Crosstree's Innovations in Pharmaceutical Development, discusses how the trend toward more global connectivity of regulatory ... Learn More ](https://www.crosstreecapital.com/videos/global-connectivity-and-pharma-development-innovation-with-steve-gens?hsLang=en) [![How Innovations across Pharma Development Delivered the COVID-19 Vaccine with Rick Cimino](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/Rick-Cimino-Still-2.png) ###### Videos #### How Innovations across Pharma Development Delivered the COVID-19 Vaccine with Rick Cimino Rick Cimino, Panelist for Crosstree's Innovations in Pharmaceutical Development, discusses how innovation across the entire Pharma Development ... Learn More ](https://www.crosstreecapital.com/videos/how-innovations-across-pharma-development-delivered-the-covid-19-vaccine-with-rick-cimino?hsLang=en) [![COVID-19 Impact on Pharma Development Innovation with Steve Sullivan](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/Steve-Sullivan-still-2.png) ###### Videos #### COVID-19 Impact on Pharma Development Innovation with Steve Sullivan Steve Sullivan, Panelist for Crosstree's Innovations in Pharmaceutical Development, discusses how COVID-19 has accelerated innovation in the Pharma ... Learn More ](https://www.crosstreecapital.com/videos/covid-19-impact-on-pharma-development-innovation-with-steve-sullivan?hsLang=en) [![PharmaVOICE: February 2021](https://www.crosstreecapital.com/hubfs/Insights/Articles/Feb-2021-Content.png) ###### Articles #### PharmaVOICE: February 2021 Fueled by the strong financial performance of Pharma Services, Diagnostics and Tools, and Digital Health companies and accelerated by the COVID-19 ... Learn More ](https://www.crosstreecapital.com/article/crosstree-in-pharmavoice-feb-2021?hsLang=en) [![Future of Clinical Trials](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/no-challenges-thumbnail.jpg) ###### Videos #### Future of Clinical Trials This video provides insights to how the future of clinical trials has been impacted by COVID-19. Learn More ](https://www.crosstreecapital.com/videos/future-of-clinical-trials?hsLang=en) [![The Prism Doctrine](https://www.crosstreecapital.com/hubfs/Imported_Blog_Media/Prism-1800x1200.jpg) ###### Market Map #### The Prism Doctrine Tomorrow’s ecosystem must allow for more specialized, complex treatments and patient journeys, which will be tailored to each therapy in the case of ... Learn More ](https://www.crosstreecapital.com/market-map/theprismdoctrine?hsLang=en) [![Precision Medicine Driving M&A](https://www.crosstreecapital.com/hubfs/Insights/Articles/Arrows_Orange2.jpg) ###### Articles #### Precision Medicine Driving M&A Increasingly complex clinical trials are putting pressure on CROs to expand their service offerings in what has been a historically monolithic space ... Learn More ](https://www.crosstreecapital.com/article/precisionmedicinedriving?hsLang=en) Load More ## Gain Insight Into The Health Sciences Industries Sign up to receive the the latest reports, research, BlueBooks, and more from the Crosstree team. [ Subscribe ](https://www.crosstreecapital.com/subscribe?hsLang=en)